Genetic Basis of Rosacea

Completed

• Conditions: Rosacea

• Registration Number: NCT02787616
• Lead Sponsor: Stanford University

Brief Summary

Rosacea is a common disease characterized by inflammation and vascular abnormalities of the facial skin and ocular surface. The exact pathogenesis of papulopustular rosacea is not well understood and current methods to treat this disease are often unsatisfactory. The purpose of this study is to develop gene expression profiles of papulopustular rosacea compared to those of normal skin. The investigators hope to better understand the abnormal gene functions that might contribute to this condition. This understanding may lead to the development of additional and better treatments for rosacea.

Detailed Description

Not available

Study Timeline

• Study Start: 2012-04-13
• Study First Submitted: 2016-04-18
• Study First Submitted QC: 2016-05-26
• Study First Posted: 2016-06-01
• Primary Completion: 2018-11-16
• Study Completion: 2018-11-16
• Status Verified: 2019-09
• Last Update Submitted: 2019-09-24
• Last Update Posted: 2019-09-26

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 306

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Targeted interrogation of alleles and assessment of rosacea co-morbidities.	Up to 2 years

Trial Locations

Locations (1)

Stanford Dermatology; 🇺🇸 Redwood City, California, United States